Yahoo Web Search

Search results

1. • Lupus Complications Reduced With Common Diabetes Drug

     MedPage Today· 3 days ago

     People with systemic lupus erythematosus (SLE) had lower rates of lupus nephritis, chronic kidney disease, and other complications when they were taking ...

2. • 

     'Unprecedented' CAR-T results for lupus net Insight prize for researchers

     FierceBiotech· 2 days ago

     Two scientists whose work sparked industry excitement about the prospect of using chimeric antigen...

3. • 

     US FDA approves Roche's drug for a chronic blood disorder

     Reuters via Yahoo News· 1 day ago

     The drug crovalimab, branded as PiaSky, is a monthly under-the-skin or intravenous treatment for...

4. • 

     Is Adicet Bio, Inc. (NASDAQ:ACET) the Best Halal Stock ?

     Insider Monkey via Yahoo Finance· 1 day ago

     We recently compiled the list of the 7 Best Halal Stocks To Buy Now (Debt Free) according to the...

5. • 

     CAR-T therapy achieves lupus remission breakthrough

     BioPharma-Reporter· 4 days ago

     This is the first trial to date to show safe elimination of all autoantibodies in patients with systemic lupus erythematosus (SLE) and lupus nephritis (...

6. • 

     Kyverna's CAR-T relapse in lupus dents autoimmune hopes amid biotech gold rush

     FierceBiotech· 5 days ago

     The “remarkable” success of chimeric antigen receptor T-cell therapy (CAR-T) in lupus has led to a...

7. • Multiscale topology classifies cells in subcellular spatial transcriptomics - Nature

     Nature· 4 days ago

     A method for topological automatic cell type classification across subcellular resolution spatial transcriptomic platforms is proposed, resolving cell type information and locating sparsely dispersed cells in human kidney and mouse kidney and brain.

8. • 

     Strength Seen in Aurinia (AUPH): Can Its 5.6% Jump Turn into More Strength?

     Zacks via Yahoo Finance· 6 days ago

     Aurinia (AUPH) saw its shares surge in the last session with trading volume being higher than...

9. • First-in-Disease Use of Kyverna Therapeutics' KYV-101 in Patient With Severe Stiff-Person Syndrome...

     Lodi News-Sentinel· 5 days ago

     Kyverna Therapeutics, Inc. (Kyverna), a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases, announced ...

10. • Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock Price Up 3.9%

      ETF DAILY NEWS· 7 days ago

      Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Free Report) (TSE:AUP) rose 3.9% on Friday . The stock traded as high as $5.60 and last traded at $5.56. Approximately 1,389,155 shares traded ...